Radioreceptor assay for sirolimus in patients with decreased platelet counts

Clinical Biochemistry

Volumn 30, Issue 7, 1997, Pages 539-543

  Goodyear, Nancy ^a,b,d   Napoli, Kimberly L ^c   Murthy, Jayasimha N ^a,d   Kahan, Barry D ^c   Soldin, Steven J ^a,b,d  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b CATHOLIC UNIVERSITY OF AMERICA   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Immunophilins; Immunosuppression; Radioreceptor assay; Rapamycin; Toxicity

Indexed keywords

CYCLOSPORIN A; RAPAMYCIN;

ARTICLE; BONE MARROW DEPRESSION; DIAGNOSTIC ACCURACY; DRUG EFFECT; DRUG MONITORING; DRUG POTENCY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; NEPHROTOXICITY; PRIORITY JOURNAL; RADIORECEPTOR ASSAY; THROMBOCYTOPENIA; TOXICITY TESTING;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LINEAR MODELS; PLATELET COUNT; POLYENES; RADIOLIGAND ASSAY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SIROLIMUS; TIME FACTORS;

EID: 0030698657     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(97)00096-9     Document Type: Article

References (18)

1. Kahan BD, Chang JY, Sehgal SN. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin. Transplantation. 52:1991;185-191.
2. Kahan BD, Gibbons S, Tejpal N, Stepkowski S, Chou TC. Synergistic interaction of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation. 51:1991;232-239.
3. Murgia MG, Jordan S, Kahan BD. The side effect profile of sirolimus a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients . Kidney Int. 49:1996;209-216.
4. Yatscoff RW, Boeckx R, Holt DW, et al. Consensus guidelines for therapeutic drug monitoring of rapamycin report of the consensus panel . Ther Drug Monit. 17:1995;676-680.
5. Napoli KL, Kahan BD. Routine clinical monitoring of sirolimus (rapamycin) whole-blood concentrations by HPLC with ultraviolet detection. Clin Chem. 42:1996;1943-1948.
6. Suthanthiran M, Morris RE, Strom TB. Immunosuppressants cellular and molecular mechanisms of action . Am Journal of Kidney Dis. 28:1996;159-172.
7. Abraham RT, Wiederrecht GJ. Immunopharmacology of rapamycin. Ann Rev Immunol. 14:1996;483-510.
8. Donnelly JG, Soldin SJ. Purification of a 50- to 58-kDa immunophilin from human spleen and a Jurkat T-cell line capable of binding cyclosporine A, FK506, and rapamycin. Trans Proc. 23:1991;2887-2890.
9. Murthy JN, Chen Y, Soldin SJ. Identification of a 14 kDa FK506/rapamycin binding immunophilin from calf thymus. Clin Biochem. 27:1994;357-365.
10. Murthy JN, Goodyear N, Soldin SJ. Identification of a 37 kDa tacrolimus, sirolimus and cyclosporine binding immunophilin possessing glyceraldehyde 3-phosphate dehydrogenase activity isolated from the JURKAT T cell line. Clin Biochem. 30:1997;129-133.
11. Soldin SJ. Receptor (immunophilin-binding) assay for immunosuppressive drugs. Ther Drug Monit. 17:1995;574-576.
12. Donnelly JG, Soldin SJ. A radioreceptor assay for the measurement of cyclosporine activity a preliminary report . Ther Drug Monit. 11:1989;696-700.
13. Soldin SJ, Murthy JN, Chen Y, Donnelly JG, Yatscoff RW. Correlation of two radioreceptor assays and the specific and nonspecific fluorescence polarization immunoassays for cyclosporine with immunosuppression as measured by the mixed lymphocyte culture assay. Trans Proc. 26:1994;2814-2817.
14. Goodyear N, Napoli KL, Murthy JN, Kahan BD, Soldin SJ. Radioreceptor assay for sirolimus. Clin Biochem. 29:1996;457-460.
15. Handschumaker RE, Harding MW, Rice J, Drugge RJ, Speicher DW. Cyclophilin: a specific binding protein for cyclosporine A. Science 984; 226: 544-7.
16. Harding MW, Galat A, Uehling DE, Schreiber SL. A receptor for the immunosuppressant FK-506 is a cis-trans peptidyl-prolyl isomerase. Nature. 341:1989;758-760.
17. Altman DG, Bland JM. Measurement in medicine the analysis of method comparison studies . Statistician. 32:1983;307-317.
18. Goodyear N, Murthy JN, Gallant HL, Yatscoff RW, Soldin SJ. Comparison of binding characteristics of four rapamycin metabolites to the 14 and 52 kDa immunophilin with their pharmacologic activity measured by the mixed-lymphocyte culture assay. Clin Biochem. 29:1996;309-313.